Literature DB >> 9378824

Small intestine in lymphocytic and collagenous colitis: mucosal morphology, permeability, and secretory immunity to gliadin.

P Moayyedi1, S O'Mahony, P Jackson, D A Lynch, M F Dixon, A T Axon.   

Abstract

There is a recognised association between the "microscopic" forms of colitis and coeliac disease. There are a variety of subtle small intestinal changes in patients with "latent" gluten sensitivity, namely high intraepithelial lymphocyte (IEL) counts, abnormal mucosal permeability, and high levels of secretory IgA and IgM antibody to gliadin. These changes have hitherto not been investigated in microscopic colitis. Nine patients (four collagenous, five lymphocytic colitis) with normal villous architecture were studied. Small intestinal biopsies were obtained by Crosby capsule; small intestinal fluid was aspirated via the capsule. IEL counts were expressed per 100 epithelial cells, and intestinal IgA and IgM antigliadin antibody levels were measured by ELISA. Small intestinal permeability was measured by the lactulose:mannitol differential sugar permeability test. IEL counts were normal in all cases, median 17, range 7-30. Intestinal antigliadin antibodies were measured in six cases and were significantly elevated in two patients (both IgA and IgM). Intestinal permeability was measured in eight cases and was abnormal in two and borderline in one. These abnormalities did not overlap: four of nine patients had evidence of abnormal small intestinal function. Subclinical small intestinal disease is common in the two main forms of microscopic colitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378824      PMCID: PMC500002          DOI: 10.1136/jcp.50.6.527

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Increased HLA A1 and diminished HLA A3 in lymphocytic colitis compared to controls and patients with collagenous colitis.

Authors:  F M Giardiello; A J Lazenby; J H Yardley; W B Bias; J Johnson; R G Alianiello; M S Bedine; T M Bayless
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

2.  Similarities in intestinal humoral immunity in dermatitis herpetiformis without enteropathy and in coeliac disease.

Authors:  S O'Mahony; J P Vestey; A Ferguson
Journal:  Lancet       Date:  1990-06-23       Impact factor: 79.321

3.  Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis.

Authors:  A J Lazenby; J H Yardley; F M Giardiello; J Jessurun; T M Bayless
Journal:  Hum Pathol       Date:  1989-01       Impact factor: 3.466

Review 4.  Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential.

Authors:  A Ferguson; E Arranz; S O'Mahony
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

5.  Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease.

Authors:  I Cobden; R J Dickinson; J Rothwell; A T Axon
Journal:  Br Med J       Date:  1978-10-14

6.  Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis.

Authors:  F M Giardiello; A J Lazenby; T M Bayless; E J Levine; W B Bias; P W Ladenson; D F Hutcheon; N L Derevjanik; J H Yardley
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

7.  Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology.

Authors:  E Arranz; A Ferguson
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

8.  Collagenous colitis: jejunal and colorectal pathology.

Authors:  J Armes; D C Gee; F A Macrae; W Schroeder; P S Bhathal
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

9.  Chronic diarrhea of unknown origin.

Authors:  N W Read; G J Krejs; M G Read; C A Santa Ana; S G Morawski; J S Fordtran
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

10.  Dissociation between systemic and mucosal humoral immune responses in coeliac disease.

Authors:  S O'Mahony; E Arranz; J R Barton; A Ferguson
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

  10 in total
  6 in total

1.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

2.  The pattern of involvement of the gastric mucosa in lymphocytic gastritis is predictive of the presence of duodenal pathology.

Authors:  M Hayat; D S Arora; J I Wyatt; S O'Mahony; M F Dixon
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

3.  Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110δ.

Authors:  Jennifer K Uno; Kavitha N Rao; Katsuyoshi Matsuoka; Shehzad Z Sheikh; Taku Kobayashi; Fengling Li; Erin C Steinbach; Antonia R Sepulveda; Bart Vanhaesebroeck; R Balfour Sartor; Scott E Plevy
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

Review 4.  Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?

Authors:  Floriana Giorgio; Mariabeatrice Principi; Giuseppe Losurdo; Domenico Piscitelli; Andrea Iannone; Michele Barone; Annacinzia Amoruso; Enzo Ierardi; Alfredo Di Leo
Journal:  Nutrients       Date:  2015-09-08       Impact factor: 5.717

5.  Dietary L-arginine supplementation protects weanling pigs from deoxynivalenol-induced toxicity.

Authors:  Li Wu; Peng Liao; Liuqin He; Zemeng Feng; Wenkai Ren; Jie Yin; Jielin Duan; Tiejun Li; Yulong Yin
Journal:  Toxins (Basel)       Date:  2015-04-15       Impact factor: 4.546

Review 6.  Towards a new paradigm of microscopic colitis: Incomplete and variant forms.

Authors:  Danila Guagnozzi; Stefania Landolfi; Maria Vicario
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.